載入...
Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
BACKGROUND: In the current study, we aimed to investigate the efficacy and safety of intravenous immunoglobulin (IVIg)-SN 10%, a new 10% IVIg formulation, in adult patients with severe primary immune thrombocytopenia (ITP; platelet count < 20 × 10(9)/L). METHODS: Patients diagnosed as primary ITP...
Na minha lista:
| 發表在: | J Korean Med Sci |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Academy of Medical Sciences
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5934518/ https://ncbi.nlm.nih.gov/pubmed/29736158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2018.33.e142 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|